Cytomegalovirus Infection With Retinitis After Brentuximab Vedotin Treatment for CD30(+) Lymphoma

Brentuximab vedotin is an antibody-conjugated chemotherapy targeting CD30 indicated in treatment of several lymphomas. We report the first 3 cases of cytomegalovirus severe infections with retinitis following this treatment. Evolution was favorable, but relapse occurred after treatment rechallenge....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Forum Infect Dis
Autors principals: Tudesq, Jean-Jacques, Vincent, Laure, Lebrun, Julie, Hicheri, Yosr, Gabellier, Ludovic, Busetto, Timothé, Merle, Corinne, Fegueux, Nathalie, Ceballos, Patrice, Quittet, Philippe, Navarro, Robert, Hillaire-Buys, Dominique, Cartron, Guillaume
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Brief Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5473439/
https://ncbi.nlm.nih.gov/pubmed/28638848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx091
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars